EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sonazoid-enhanced ultrasound for preoperative localization and characterization of sentinel lymph nodes in patients with cutaneous melanoma

Binbin Jiang, Liqi Sun, Lu Si, Jiayong Liu, Chuanliang Cui, Kun Yan, Shanshan Yin

European Radiology · 2026

DOI: 10.1007/s00330-026-12640-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Radiology, 2026. Verfasst von Binbin Jiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasonography, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer …. Hauptthemen laut MEDLINE: Melanoma, Oxides, Skin Neoplasms, Sentinel Lymph Node. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science Foundation of Peking University Cancer Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Accurate sentinel lymph node (SLN) identification is essential for the staging of cutaneous melanoma. Contrast-enhanced ultrasound using Sonazoid (Sonazoid-CEUS), which is based on a perfluorobutane microbubble contrast agent with reticuloendothelial uptake properties, was evaluated for SLN detection in patients with stage Ib–II melanoma. Materials and methods In this prospective single-arm cohort study, 71 eligible subjects underwent perilesional intradermal Sonazoid-CEUS, followed by lymphoscintigraphy and SLN biopsy. The numbers of SLNs detected via CEUS and lymphoscintigraphy were compared by using non-parametric paired analysis (Wilcoxon signed-rank test). The diagnostic accuracy of CEUS for metastatic involvement was evaluated against histopathological results.

Results

Sonazoid-CEUS achieved a 97.3% success rate in identifying SLNs, detecting 148 SLNs, with an average of 2.1 ± 1.1 SLNs per patient. Most patients (93.0%) had single-basin lymphatic drainage. For metastasis detection, CEUS demonstrated 82.1% sensitivity, 88.4% specificity, and 85.9% accuracy. Ulceration, high mitotic count, and HMB45 positivity in primary lesions were significantly associated with SLN metastasis. No contrast-related adverse events were observed.

Conclusion

Sonazoid-CEUS is a safe and accurate non-radioactive technique for SLN identification and preoperative diagnosis in patients with cutaneous melanoma; moreover, it exhibits potential value as a complementary imaging modality within established SLNB workflows. Key Points Question Can a non-radioactive contrast-enhanced ultrasound technique using Sonazoid improve preoperative localization and characterization of sentinel lymph nodes in patients with cutaneous melanoma?

Findings

In this prospective study, Sonazoid-CEUS identified sentinel lymph nodes in 97.3% of patients and showed high diagnostic accuracy without contrast-related adverse events. Clinical relevance Sonazoid-CEUS provides a non-radioactive adjunct for preoperative sentinel lymph node mapping and characterization in cutaneous melanoma, thereby potentially improving surgical planning while offering complementary functional information alongside conventional lymphoscintigraphy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaOxidesSkin NeoplasmsSentinel Lymph NodeIronFerric CompoundsHumansFemaleMaleMiddle AgedContrast MediaAgedUltrasonographyProspective StudiesSensitivity and SpecificityAdultLymphatic MetastasisSentinel Lymph Node BiopsyAged, 80 and overCutaneous Malignant MelanomaPreoperative Care

Stichwörter der Autor:innen

Lymphatic metastasisMelanomaSentinel lymph node biopsySonazoidUltrasonography

Substanzen

SonazoidOxidesIronContrast MediaFerric Compounds

Autor:innen und Institutionen

  • Department of Ultrasonography, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, China.
  • Department of Ultrasound, The Second Hospital Affiliated with the Southern University of Science and Technology (Shenzhen Third People's Hospital), Shenzhen, China.
  • Department of Melanoma and Sarcoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing, China.
  • Department of Bone and Soft Tissue Tumor, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, China.
  • Department of Ultrasonography, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, China. yshshmd2013@163.com.
  • Peking University Cancer Hospital (Inner Mongolia Campus) & Affiliated Cancer Hospital of Inner Mongolia Medical University, Huhhot, China. yshshmd2013@163.com.

Förderung

  • Science Foundation of Peking University Cancer Hospital

Zitieren

APA

Jiang, B., Sun, L., Si, L., Liu, J., Cui, C., Yan, K., & Yin, S. (2026). Sonazoid-enhanced ultrasound for preoperative localization and characterization of sentinel lymph nodes in patients with cutaneous melanoma. European Radiology. https://doi.org/10.1007/s00330-026-12640-2

Vancouver

Jiang B, Sun L, Si L, Liu J, Cui C, Yan K, et al. Sonazoid-enhanced ultrasound for preoperative localization and characterization of sentinel lymph nodes in patients with cutaneous melanoma. European Radiology. 2026. doi:10.1007/s00330-026-12640-2

BibTeX
@article{Jiang2026,
  author = {Jiang, Binbin and Sun, Liqi and Si, Lu and Liu, Jiayong and Cui, Chuanliang and Yan, Kun and Yin, Shanshan},
  title = {Sonazoid-enhanced ultrasound for preoperative localization and characterization of sentinel lymph nodes in patients with cutaneous melanoma},
  journal = {European Radiology},
  year = {2026},
  doi = {10.1007/s00330-026-12640-2}
}
Kostenlos starten →